REDWOOD CITY, Calif. – April 17, 2001 – iScribe, a leading developer of handheld technology solutions that enable physicians to efficiently perform routine healthcare transactions at the point of care, announced it has closed $15 million in Series D financing. Led by new investor Earlybird, and joined by previous investors Kleiner Perkins Caufield and Byers, Galen Partners, Domain Associates and other investors, this round of funding demonstrates the continued interest in the physician handheld prescribing and point-of-care services market.

“iScribe’s momentum in the market has been increasing. Investors have demonstrated their commitment to and belief in iScribe’s handheld platforms for delivering physician-directed services at the point of care,” said David Levison, iScribe President and Chief Executive Officer. “Other electronic prescribing initiatives recently announced by established companies in the healthcare and technology market have validated the interest in point of care initiatives. The success iScribe has already shown within the physician community positions the company for continued leadership in this growing segment.”

With the closing of this financing, iScribe named Vera Kallmeyer, M.D., Ph.D., Partner at Earlybird, to the Board of Directors. In joining iScribe\'s board. Dr. Kallmeyer brings with her physician experience as well as a strong European network from Earlybird’s international operations.

\"We expect physicians will increasingly use handheld devices as their enhanced functionality beyond prescribing makes physicians’ day-to-day activities both more efficient and safe,” said Dr. Kallmeyer. “We see iScribe as one of the winners in this space as they have developed one of the most robust and practice management system-compatible – yet intuitive and easy to use –technology solutions. In addition, they have secured strategic partnerships with several established healthcare players important to market acceptance and penetration.”

Other members of iScribe’s Board of Directors include David Levison, President and CEO, iScribe; Brook Byers, Partner, Kleiner Perkins Caufield and Byers; Wende Hutton, General Partner, Mayfield Fund; Alan Mendelson, Senior Partner, Latham & Watkins; and L. John Wilkerson, Ph.D, Founding General Partner, Galen.



About iScribe

iScribe was founded in January 1999 to eliminate inefficiencies in the healthcare system through the development of a pocket-sized, wireless system that would automate the process of prescribing drugs, capturing charges and ordering laboratory tests. Physicians, pharmacists, patients, pharmacy benefit managers, managed care organizations and pharmaceutical companies can all benefit from use of this system, which can help reduce paperwork and safeguard the process of writing and filling prescriptions. Based in Redwood City, CA, iScribe is backed by several leading venture capital firms in healthcare and e-commerce technology. iScribe can be reached through its Website at www.iscribe.com.

Contact iScribe: David Levison (President and CEO): +1 (650) 381-2000



About Earlybird

Earlybird is an international venture capital fund with about $300 million under management and investment focus on information technology, telecommunications and healthcare. With offices in Europe (Hamburg, Munich) and the US (Palo Alto), Earlybird is well positioned to take advantage of international opportunities and to assist its portfolio companies to gain access to the international market place and financial resources. Earlybird\'s investment professionals have extensive finance and start-up operating experience and actively support portfolio companies. In addition, a network of experienced industry specialists serves on the Earlybird advisory board and assists Earlybird and its portfolio companies in providing strategic advice and operational support. Additional information about Earlybird can be found at www.earlybird.com